Despite this potential, the current study requires deepening to cover other markers (with clinical relevance) such as the presence of PD-1 and PD-L1 (immune checkpoints and their ligands) to correlate immune cell infiltration with the expression of these markers in NB tumours [57]. The gene discussed is CD274; the disease is neuroblastoma.